This summer the Food and Drug Administration (FDA) issued a number of warnings, which should also concern caregivers and elders in their charge.
The best FDA drugs has announced new warnings for three different classes of drugs:
Those for pain and inflammation.
Those that lower cholesterol
Those that help treat anemia in some patients.
Pain and Inflammation Drugs
It is a group of drugs commonly called non-steroidal anti-inflammatory drugs or NSAIDs. You will recognize the brand name, Aleve, Motrin, Advil or Nupine as well as their generic name, Naproxen or ibuprofen and many people use them to good effect.
The "family" of medications most commonly used to lower cholesterol is called statins and includes some very well-known brands that many of you have seen advertised on television and in magazines. Others of you or the people you care for may also be taking these medications.
Medications that Treat Anemia
The third FDA warning was about some of the dosing for drugs that are used for people who may be anemic or suffer from chronic kidney disease or be on chemotherapy of some sort. As you may suspect, this is a relatively smaller segment of the adult population, and as you will see here, it gets even smaller as we are mainly talking about people with chronic kidney disease.
In 2009, the US Food and Drug Administration (FDA) increased the number of warning letters sent to drug manufacturers about their advertising practices. The number of warnings issued was twice as high as in 2008.
The main complaint the FDA has in most of its warning letters is the misleading claims and overvaluing the benefits of some drugs that are untrue.
If you want to see the list who have received FDA warning letter, then you may browse https://wizmed.com/fda-warning-letters.
However, this warning can be avoided if the company has used pharmaceutical consultants to advise on their advertising strategy.
Image Source: Google
As you can see, it is not only the production process that can help pharmaceutical advice. There are strict regulations for the advertising, marketing and promotion of drugs. Therefore, manufacturers need to know what they can and cannot say about their products.
The over-effectiveness of the drug is a big prohibition if there is no evidence to support it. For example, photos and quotes from people who say that acne medication gives them completely clean and imperfect skin are overly excited because nothing from any research or research proves it.
Another example when promotional material could be classified as misleading is disease-specific drugs. Antiallergens targeting seasonal allergy treatments such as hay fever cannot be advertised as allergy relief from dust or for cleaning the house.
These types of manufacturer claims would have been avoided had pharmaceutical recommendations been used. In contrast, the company now faced reputational damage, lost profits, and an aura of suspicion in the future.